18 May 2013
Keywords: merck, co/lundbeck, delay, gabodaxol, filing, drug, major
Article | 23 October 2006
US drug major Merck & Co and Denmark's H Lundbeck AS have delayed their submission of a New Drug Application for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2006
17 May 2013
© 2013 thepharmaletter.com